Approach to risk stratification of atherosclerotic cardiovascular disease

Abstract

Objective To outline the 2021 Canadian Cardiovascular Society (CCS) dyslipidemia guidelines and to present the current approaches to cardiovascular risk stratification, including the incorporation of biomarkers and imaging tests. Sources of informationCurrent guidelines were reviewed and an Ovid MEDLINE literature search was performed.This article is eligible for Mainpro+ certified Self-Learning credits. To earn credits, go to https://www.cfp.ca and click on the Mainpro+ link. This article has been peer reviewed.

Recommendations for the primary prevention of atherosclerotic cardiovascular disease in primary care: study protocol for a systematic guideline review

“…Similar to other developed countries, cardiovascular disease (CVD) is the main cause of death in Germany, with 33% of all deaths being attributable to it in 2021 1. Atherosclerotic CVD (ASCVD) involves the build-up of cholesterol plaque in the coronary, cerebral, iliac and femoral arteries and the aorta, and includes mainly coronary heart disease, stroke and transient ischaemic attacks, peripheral artery disease and aortic disease 2. The most important modifiable ASCVD risk factors include hypertension, diabetes, dyslipidaemia, obesity and certain lifestyles, such as smoking, physical inactivity and unhealthy diet 3 4.…”

“…1 Atherosclerotic CVD (ASCVD) involves the build-up of cholesterol plaque in the coronary, cerebral, iliac and femoral arteries and the aorta, and includes mainly coronary heart disease, stroke and transient ischaemic attacks, peripheral artery disease and aortic disease. 2 The most important modifiable ASCVD risk factors include hypertension, diabetes, dyslipidaemia, obesity and certain lifestyles, such as smoking, physical inactivity and unhealthy diet. 3 4 Almost every third adult in Germany (31% of women and 33% of men) has been diagnosed with high blood pressure.…”